Court Blocks Mifepristone Mail Delivery, Access at Risk

Summary

A federal appeals court has blocked the mail delivery of mifepristone, the most common abortion pill in the U.S., requiring in-person pickups at clinics. This decision, which overrides FDA rules, has sparked controversy, with abortion rights groups warning of reduced access for rural, low-income, and disabled individuals, and anti-abortion advocates haili…

Show notes

A federal appeals court has blocked the mail delivery of mifepristone, the most common abortion pill in the U.S., requiring in-person pickups at clinics. This decision, which overrides FDA rules, has sparked controversy, with abortion rights groups warning of reduced access for rural, low-income, and disabled individuals, and anti-abortion advocates hailing it as a safety win. The ruling, which sets up a fast track to the Supreme Court, has significant implications for abortion access nationwide

Themes

• daily